These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24052436)

  • 41. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
    Zhang H; Liu H; Knauss JL
    Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of XRCC1 genetic polymorphism (Arg399Gln) with laryngeal cancer: a meta-analysis based on 4,031 subjects.
    Chen W; Wang ZY; Xu FL; Wu KM; Zhang Y; Xu L; Wang QP
    Tumour Biol; 2014 Feb; 35(2):1637-40. PubMed ID: 24194393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.
    Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C
    Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.
    Liu BM; Liu TM; You BS; You HY; Yang J; Li L; He YC
    Genet Mol Res; 2012 Nov; 11(4):3852-60. PubMed ID: 23212324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
    Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
    Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies.
    Chen J; Zhao QW; Shi GM; Wang LR
    J Zhejiang Univ Sci B; 2012 Nov; 13(11):875-83. PubMed ID: 23125080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis.
    Zhang F; Wu JH; Zhao W; Liu HT
    Tumour Biol; 2013 Oct; 34(5):2659-64. PubMed ID: 23636799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Arg399Gln polymorphism in the XRCC1 gene is associated with increased risk of hematological malignancies.
    Du L; Liu Y; Xue P; Song C; Shen J; He Q; Peng Y; Tong X; Tang L; Zhang Y
    Tumour Biol; 2015 Jun; 36(6):4545-54. PubMed ID: 25619474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.
    Bao Y; Jiang L; Zhou JY; Zou JJ; Zheng JY; Chen XF; Liu ZM; Shi YQ
    PLoS One; 2013; 8(5):e64851. PubMed ID: 23717668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
    Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM
    Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between X-ray repair cross-complementing group 1 Arg399Gln polymorphism and male infertility: An update meta-analysis.
    Lv MQ; Li YX; Ge P; Yang YQ; Zhang J; Han SP; Zhou DX
    Andrologia; 2020 Oct; 52(9):e13700. PubMed ID: 32535968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
    Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
    Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and meta-analysis.
    Shuai HL; Luo X; Yan RL; Li J; Chen DL
    Asian Pac J Cancer Prev; 2012; 13(12):6423-7. PubMed ID: 23464469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between Polymorphisms of X-Ray Repair Cross Complementing Group 1 Gene and Pancreatic Cancer Risk: a Systematic Review with Meta-Analysis.
    Chen J; Wang H; Li Z
    Pathol Oncol Res; 2019 Jul; 25(3):897-904. PubMed ID: 29285737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.
    Lou Y; Peng WJ; Cao DS; Xie J; Li HH; Jiang ZX
    PLoS One; 2013; 8(9):e74059. PubMed ID: 24086310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls.
    Zhuo W; Zhang L; Cai L; Zhu B; Chen Z
    Exp Biol Med (Maywood); 2013 Jan; 238(1):66-76. PubMed ID: 23479765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between Arg399Gln polymorphism of X-ray repair cross-complementing 1 (XRCC1) gene and sporadic endometrial cancer in the Polish population.
    Samulak D; Romanowicz-Makowska H; Smolarz B; Kulig A; Sporny S
    Eur J Gynaecol Oncol; 2011; 32(5):491-5. PubMed ID: 22053659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.